Earnings Snapshot: SBI Life Insurance, COFORGE, Dr. Reddy’s Laboratories, SBI Card and Kotak Mahindra Bank

SBILIFE₹1,898.10 +3.17%

Net Premium Income ₹24,848.31 crore 🔼 22.61%
PAT ₹494.59 crore 🔻 6.58%

SBI Life Insurance Company Limited (SBI Life) reported strong growth in premium income for the quarter ended September 30, 2025, although the quarter saw a slight contraction in net profitability. The Gross Premium Income surged by 22.61% YoY for the quarter ended September 30, 2025, reaching ₹24,848.31 crore, up from ₹20,266.10 crore in the same quarter of the previous year.

COFORGE₹1,833.00 +4.15%

Revenue from Operations ₹3,985.7 crore 🔼 31.7%

PAT ₹375.8 crore 🔼 86.0%

Coforge Limited reported strong financial results for the quarter ended September 30, 2025, marked by substantial YoY growth. The company secured a Total Contract Value (TCV) order intake of $514 Million during the quarter and signed 5 large deals across North America and APAC. Growth was well-diversified, with the Travel, Transportation & Hospitality (TTH) segment experiencing the highest growth (60.8% YoY), followed by Banking and Financial Services (17.4% YoY).

DRREDDY₹1,285.20 +0.09%

Revenue ₹8,805.1 crore 🔼 9.8%

PAT ₹1,437.2 crore 🔼 14%

Dr. Reddy’s achieved 9.8% revenue growth YoY, despite softness in the US generics market. The company’s EBITDA for the quarter stood at ₹2,351.1 crore, representing a 26.7% margin and a 3% increase YoY. The growth was primarily driven by momentum in branded markets and steady contributions from the acquired Nicotine Replacement Therapy (NRT) portfolio, which helped offset the decline in U.S. Lenalidomide sales.

SBICARD₹902.00 -2.90%

Revenue ₹4,960.98 crore 🔼 12%

PAT ₹444.77 crore 🔼 10% 

SBI Cards achieved a 12% YoY increase in revenue from operations to ₹4,960.98 crore, compared to ₹4,421.04 crore reported in the corresponding quarter last year. This quarter’s performance was marked by effective management of credit quality, with credit cost declining to 9.0%, indicating an improving risk profile. The company successfully launched three marquee co-brand products during the quarter, including collaborations with PhonePe, Flipkart, and IndiGo.

KOTAKBANK₹2,153.20 -1.55%

Net Interest Income ₹7,311 crore 🔼 4%

PAT ₹4,468 crore 🔻 11% 

Kotak Mahindra Bank reported mixed consolidated results for Q2FY26, with operational metrics showing robust expansion, though overall group profitability declined due to the performance of its subsidiaries. The core bank demonstrated strong balance sheet growth, with Net Advances rising 16% YoY to ₹ 4,62,688 crore and Average Total Deposits growing 14% YoY to ₹ 5,10,538 crore.

Note: The stock prices mentioned are as of 2:25 PM.